Bispecific CD20-directed CD3 T Cell Engager

All categories
DBCAT005988Therapeutic category

A DrugBank category of 2 drugs. 2 of them are approved.

Drugs

What you can answer from here — as of February 12, 2025

2DrugsEach linked to its full drug card
Listed above
3Drug targetsEvery drug–target pair in the class, with bond type
Sign in
16Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
3Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Bispecific CD20-directed CD3 T Cell Engager share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In